Ligand Pharmaceuticals RSS Feed | Nachrichten - www.finanzen.netwww.finanzen.net bietet Finanznachrichten zum weltweiten Boersengeschehenhttp://www.finanzen.netde-definanzen.net GmbHhttp://images.finanzen.net/images/finanzen_net_neu.gifFinanzen.nethttp://www.finanzen.netLigand to Present at the Jefferies 2011 Global Healthcare Conference on June 4http://www.finanzen.net/nachricht/Ligand-to-Present-at-the-Jefferies-2011-Global-Healthcare-Conference-on-June-4-1864211 <style type="text/css"> <!-- .bwalignc {text-align: center} .bwalignl {text-align: left} --> </style> <!-- sh_cad_1 --> <b>Ligand Pharmaceuticals Incorporated (NASDAQ: LGND)</b> announced today that John Higgins, President and Chief ...http://www.finanzen.net/nachricht/Ligand-to-Present-at-the-Jefferies-2011-Global-Healthcare-Conference-on-June-4-1864211Ligand to Present at the Bank of America Merrill Lynch 2012 Health Care Conference on May 17http://www.finanzen.net/nachricht/Ligand-to-Present-at-the-Bank-of-America-Merrill-Lynch-2012-Health-Care-Conference-on-May-17-1848395 <style type="text/css"> <!-- .bwalignc {text-align: center} --> </style> <b>Ligand Pharmaceuticals Incorporated (NASDAQ: LGND)</b> announced today that John Higgins, President and Chief Executive Officer will present at the ...http://www.finanzen.net/nachricht/Ligand-to-Present-at-the-Bank-of-America-Merrill-Lynch-2012-Health-Care-Conference-on-May-17-1848395Ligand Pharmaceuticals Reports First Quarter Resultshttp://www.finanzen.net/nachricht/Ligand-Pharmaceuticals-Reports-First-Quarter-Results-1837210 <style type="text/css"> <!-- .bwalignc {text-align: center} .bwalignl {text-align: left} .bwalignr {text-align: right} .bwcellpmargin {margin-bottom: 0px; margin-top: 0px} .bwdoublebottom {border-bottom: double black 2.25pt} .bwlistitemmargb {margin-bottom: ...http://www.finanzen.net/nachricht/Ligand-Pharmaceuticals-Reports-First-Quarter-Results-1837210Ligand to Report First Quarter Results on May 2ndhttp://www.finanzen.net/nachricht/Ligand-to-Report-First-Quarter-Results-on-May-2nd-1797497 <style type="text/css"> <!-- .bwalignc {text-align: center} .bwalignl {text-align: left} .bwcellpmargin {margin-bottom: 0px; margin-top: 0px} .bwnowrap {white-space: nowrap} .bwpadl0 {padding-left: 0.0px} .bwpadr0 {padding-right: 0.0px} .bwtablemarginb ...http://www.finanzen.net/nachricht/Ligand-to-Report-First-Quarter-Results-on-May-2nd-1797497Ligand to Present at the 24th Annual Roth Conference on March 12http://www.finanzen.net/nachricht/Ligand-to-Present-at-the-24th-Annual-Roth-Conference-on-March-12-1708685 <style type="text/css"> <!-- .bwalignc {text-align: center} --> </style> <b>Ligand Pharmaceuticals Incorporated (NASDAQ: LGND)</b> announced today that John Higgins, President and Chief Executive Officer and Matt Foehr, Chief ...http://www.finanzen.net/nachricht/Ligand-to-Present-at-the-24th-Annual-Roth-Conference-on-March-12-1708685Ligand to Present at the Citi Global Health Care Conference on February 28thhttp://www.finanzen.net/nachricht/Ligand-to-Present-at-the-Citi-Global-Health-Care-Conference-on-February-28th-1670408 <style type="text/css"> <!-- .bwalignc {text-align: center} --> </style> <b>Ligand Pharmaceuticals Incorporated (NASDAQ: LGND)</b> announced today that John Higgins, President and Chief Executive Officer of Ligand, will present ...http://www.finanzen.net/nachricht/Ligand-to-Present-at-the-Citi-Global-Health-Care-Conference-on-February-28th-1670408Ligand Licenses DARA Program to Retrophinhttp://www.finanzen.net/nachricht/Ligand-Licenses-DARA-Program-to-Retrophin-1669518 <style type="text/css"> <!-- .bwalignc {text-align: center} .bwuline {text-decoration: underline} --> </style> <!-- sh_cad_1 --> <b>Ligand Pharmaceuticals Incorporated (NASDAQ: LGND)</b> and <b>Retrophin, LLC</b> announced that the ...http://www.finanzen.net/nachricht/Ligand-Licenses-DARA-Program-to-Retrophin-1669518Ligand to Present at the BIO CEO and Investor Conference on February 13http://www.finanzen.net/nachricht/Ligand-to-Present-at-the-BIO-CEO-and-Investor-Conference-on-February-13-1637186 <style type="text/css"> <!-- .bwalignc {text-align: center} --> </style> <b>Ligand Pharmaceuticals Incorporated (NASDAQ: LGND)</b> announced today that John Higgins, President and Chief Executive Officer of Ligand will present ...http://www.finanzen.net/nachricht/Ligand-to-Present-at-the-BIO-CEO-and-Investor-Conference-on-February-13-1637186Ligand Reports Fourth Quarter and Full Year 2011 Financial Resultshttp://www.finanzen.net/nachricht/Ligand-Reports-Fourth-Quarter-and-Full-Year-2011-Financial-Results-1630053 <style type="text/css"> <!-- .bwalignc {text-align: center} .bwalignl {text-align: left} .bwalignr {text-align: right} .bwcellpmargin {margin-bottom: 0px; margin-top: 0px} .bwdoublebottom {border-bottom: double black 2.25pt} .bwlistitemmargb {margin-bottom: ...http://www.finanzen.net/nachricht/Ligand-Reports-Fourth-Quarter-and-Full-Year-2011-Financial-Results-1630053Ligand Names Nishan de Silva, M.D., Vice President of Corporate Developmenthttp://www.finanzen.net/nachricht/Ligand-Names-Nishan-de-Silva-M-D-Vice-President-of-Corporate-Development-1628615 <style type="text/css"> <!-- .bwalignc {text-align: center} --> </style> <b>Ligand Pharmaceuticals Incorporated (NASDAQ: LGND)</b> announces the appointment of Nishan de Silva, M.D., as Vice President of Corporate Development. ...http://www.finanzen.net/nachricht/Ligand-Names-Nishan-de-Silva-M-D-Vice-President-of-Corporate-Development-1628615